Immunosuppression impact on long-term cardiovascular complications after liver transplantation

American Journal of Surgery

Volumn 183, Issue 5, 2002, Pages 595-599

  Rabkin, John M ^a   Corless, Christopher L ^a   Rosen, Hugo R ^b   Olyaei, Ali J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cardiovascular complications; Liver transplantation; Nephrotoxicity

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ALCOHOL LIVER CIRRHOSIS; ANGIOPLASTY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CONSULTATION; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FOLLOW UP; GRAFT REJECTION; HEART FAILURE; HEART INFARCTION; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER TRANSPLANTATION; NEPHROTOXICITY; PRIORITY JOURNAL; SURGICAL MORTALITY;

CARDIOVASCULAR DISEASES; CYCLOSPORINE; FEMALE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TACROLIMUS; TIME FACTORS;

EID: 0036270101     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)00826-7     Document Type: Conference Paper

References (29)

1. Atherosclerotic complications after renal transplantation
2. Evolution and etiology of cardiovascular diseases in renal transplant recipients
3. Coronary artery disease and liver transplantation: The state of the art
4. Cardiovascular risk factors and late cardiovascular disease in liver transplantation
5. Late mortality after orthotopic liver transplantation
6. Posttransplant hypertension
7. Coronary artery disease in patients with renal failure
8. Ischaemic heart disease following renal transplantation
9. Cardiovascular risk factors in kidney transplantation
10. Cardiovascular disease after renal transplantation
11. Epidemiology of cardiovascular risk factors in chronic renal disease
12. Heart disease in non-heart transplant recipients
13. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight
14. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients
15. A practical guide to the management of hypertension in renal transplant recipients
16. Posttransplantation hypertension related to calcineurin inhibitors
17. Cyclosporin-induced hypertension: Incidence, pathogenesis and management
18. Late hypertension after liver transplantation: A comparison of cyclosporine and tacrolimus (FK 506)
19. Serum cholesterol changes in long-term survivors of liver transplantation: A comparison between cyclosporine and tacrolimus therapy
20. Common medical diseases after liver transplantation
21. Cholesterol levels long-term after liver transplant
22. Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?
23. Risk factors for premature coronary heart disease after successful liver transplantation in adults
24. Coronary revascularization after liver transplantation
25. Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation
26. Immunosuppressant-induced nephropathy: Pathophysiology, incidence and management
27. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow
28. Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation